Pedro Rodriguez Cutillas

Has grant

Professor of Cell Signalling & Proteomics

Barts Cancer Institute

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Cancer Biology Cancer Biology professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Pedro Rodriguez Cutillas is a Professor of Cell Signalling & Proteomics at Barts Cancer Institute. Based in the UK, his research focuses on drug response prediction models, maternal immune activation impacts on neural stem cells, and proteomic characterization in cancer research. His recent publications include work on therapeutic targets for ovarian cancer and the role of specific proteins in tumor immune response.

Recent Grants

Grant: Close

Validation of targets in AML

Open Date: 2016-01-01

Close Date: 2016-08-01

Grant: Close

Systematic classification of phosphorylation sites for an integrative analysis of kinase signalling

Open Date: 2015-04-26

Close Date: 2018-04-25

Grant: Close

Personalizing cancer therapies

Open Date: 2015-04-01

Close Date: 2017-03-01

Grant: Close

Role of PAK in AML

Open Date: 2014-10-01

Close Date: 2017-09-01

Grant: Close

Systems biology of PI3K signalling

Open Date: 2011-10-01

Close Date: 2015-09-01

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Collaborators (11)

Natasha Clayton

University of Bristol

UNITED KINGDOM

View details

John G. Gribben

Queen Mary University of London

UNITED KINGDOM

View details

Mirjana Kessler

Head of the Research Lab

LMU Klinikum

GERMANY

View details

Kimberly Alonge

Associate Professor

University of Florida

UNITED STATES

View details

Shirin Elizabeth Khorsandi

King’s College London

UNITED KINGDOM

View details

Jalid Sehouli

GERMANY

View details

Salvatore Santamaria

Lecturer in Cardiovascular Science

University of Surrey

UNITED KINGDOM

View details

Edward Carter

Lecturer in Pharmacology

University of Bath

UNITED KINGDOM

View details

Kevin Rouault-Pierre

Senior Lecturer

Barts Cancer Institute

UNITED KINGDOM

View details

Conrad Bessant

Queen Mary University of London

UNITED KINGDOM

View details

Richard P Grose

Queen Mary University of London

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Pedro Rodriguez Cutillas

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (15)

Understanding the sources of performance in deep drug response models reveals insights and improvements

Maternal immune activation imprints translational dysregulation and differential MAP2 phosphorylation in descendant neural stem cells

Comparison of multiple modalities for drug response prediction with learning curves using neural networks and XGBoost

Versican Associates with Tumor Immune Phenotype and Limits T-cell Trafficking via Chondroitin Sulfate

Exactly defined molecular weight poly(ethylene glycol) allows for facile identification of PEGylation sites on proteins

HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via PHLDA1 Induction

Community detection in empirical kinase networks identifies new potential members of signalling pathways

In Silico Analysis Predicts Nuclear Factors NR2F6 and YAP1 as Mesenchymal Subtype-Specific Therapeutic Targets for Ovarian Cancer Patients

Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine

Principles of phosphoproteomics and applications in cancer research

Proximity proteomics identifies septins and PAK2 as decisive regulators of actomyosin-mediated expulsion of von Willebrand factor

Systematic identification of biochemical networks in cancer cells by functional pathway inference analysis

eEF2K Activity Determines Synergy to Cotreatment of Cancer Cells With PI3K and MEK Inhibitors

Targeting the lysine-specific demethylase 1 rewires kinase networks and primes leukemia cells for kinase inhibitor treatment

Computational Analysis of Cholangiocarcinoma Phosphoproteomes Identifies Patient-Specific Drug Targets

Collaborators (11)

Natasha Clayton

John G. Gribben

Mirjana Kessler

Kimberly Alonge

Shirin Elizabeth Khorsandi

Jalid Sehouli

Salvatore Santamaria

Edward Carter

Kevin Rouault-Pierre

Conrad Bessant

Richard P Grose

Make your next move.